drugset / Trial / NCT00490724

An Exploratory Study of Nesiritide in Participants With Acute Heart Failure

NCT00490724

Phase 2 Completed 67 enrolled Janssen Pharmaceutical K.K.
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this exploratory study is to assess the efficacy and safety of nesiritide in participants with acute (a quick and severe form of illness in its early stage) heart failure (when the heart inadequately pumps blood through the body) including acute exacerbation of chronic (lasting a long time) heart failure, administered intravenous (into a vein) bolus (a large amount) followed by intravenous infusion (a fluid or a medicine delivered into a vein by way of a needle).

Timeline

Start
2007-03
Primary completion
2008-06
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Nesiritide Protein / enzyme biologic 0.005 ug/kg Intravenous
Subject Nesiritide Protein / enzyme biologic 0.01 ug/kg Intravenous